Prof Malú Gámez Tansey
@malutansey.bsky.social
Stanford, UTSW, WashU, Emory, UF & now Indiana Uni SOM Stark Neuroscience. Latina, mother, daughter. Immunity inflammation lysosomes neuroimmuno neurodegen, EIC NPJPARKD. Posts my own.
Pinned
#TanseyLab4ptO @iusm-medneuro.bsky.social #StarkNeuroscienceResearchInstitute #Indianapolis
We study how inflammation & immune responses impact brain health and the risk or progression of neurodegenerative diseases (PD,AD, FTD, MS) with a focus on the connection between the gut and the brain 🧠
We study how inflammation & immune responses impact brain health and the risk or progression of neurodegenerative diseases (PD,AD, FTD, MS) with a focus on the connection between the gut and the brain 🧠
Excited and proud to share this publication from Julian Mark #TanseyLab3ptO MDPhD at Univ of Florida and team including his lab mentor Rebecca Wallings in collaboration Dzamko lab at Univ of Sydney and Garrido lab in Barcelona funded by MJFF
doi.org/10.1002/mds....
doi.org/10.1002/mds....
Parkinson's‐Linked LRRK2 and GBA1 Mutations Modulate the Peripheral Immune Response to Pseudomonas aeruginosa
Background
Peripheral disease mechanisms such as immune dysregulation may contribute to Parkinson's disease (PD). To investigate interactions between common PD mutations and immune responses to envi.....
doi.org
November 20, 2025 at 3:18 AM
Excited and proud to share this publication from Julian Mark #TanseyLab3ptO MDPhD at Univ of Florida and team including his lab mentor Rebecca Wallings in collaboration Dzamko lab at Univ of Sydney and Garrido lab in Barcelona funded by MJFF
doi.org/10.1002/mds....
doi.org/10.1002/mds....
Reposted by Prof Malú Gámez Tansey
Bial provide an update on their Phase 2 "ACTIVATE" study (NCT05819359), evaluating the efficacy, safety, tolerability, PK/PD of their GCase activator BIA 28-6156 in 273 genetically confirmed GBA1-associated #Parkinsons patients; LPLV=April 2026
www.bial.com/en/media/new...
www.bial.com/en/media/new...
Key Milestone in ACTIVATE Phase 2 Clinical Trial of BIA 28-6156
Key Milestone in ACTIVATE Phase 2 Clinical Trial of BIA 28-6156
www.bial.com
October 2, 2025 at 9:09 PM
Bial provide an update on their Phase 2 "ACTIVATE" study (NCT05819359), evaluating the efficacy, safety, tolerability, PK/PD of their GCase activator BIA 28-6156 in 273 genetically confirmed GBA1-associated #Parkinsons patients; LPLV=April 2026
www.bial.com/en/media/new...
www.bial.com/en/media/new...
Reposted by Prof Malú Gámez Tansey
WPC Vice-President, Professor @malutansey.bsky.social shares about the Fuel the Future of #Parkinsons Science campaign to support early-career researchers by providing travel grants to attend the 7th World Parkinson Congress #wpc2026 in May 2026 in #Phoenix.
Support -> wpc2026.org/supportresea...
Support -> wpc2026.org/supportresea...
September 2, 2025 at 6:31 PM
WPC Vice-President, Professor @malutansey.bsky.social shares about the Fuel the Future of #Parkinsons Science campaign to support early-career researchers by providing travel grants to attend the 7th World Parkinson Congress #wpc2026 in May 2026 in #Phoenix.
Support -> wpc2026.org/supportresea...
Support -> wpc2026.org/supportresea...
Thank you Stephen Curry for your leadership on this exciting blog post and collaborative publication in @PLOSBIOLOGY on ending #publicationbias written after a workshop hosted by The National Institutes of Health. occamstypewriter.org/scurry/2025/...
Let’s get negative about scholarly publishing | Reciprocal Space
occamstypewriter.org
September 25, 2025 at 12:52 PM
Thank you Stephen Curry for your leadership on this exciting blog post and collaborative publication in @PLOSBIOLOGY on ending #publicationbias written after a workshop hosted by The National Institutes of Health. occamstypewriter.org/scurry/2025/...
Incredibly impressed during the VIB-Ghent Center for Inflammation Research site visit. Congrats to its Director Bart Lambrecht and the entire team 🤓🧠💪🏼
September 18, 2025 at 2:58 PM
Incredibly impressed during the VIB-Ghent Center for Inflammation Research site visit. Congrats to its Director Bart Lambrecht and the entire team 🤓🧠💪🏼
Reposted by Prof Malú Gámez Tansey
New review from @malutansey.bsky.social & colleagues explores iron mishandling in the brain & periphery in #Parkinsons, & proposes that iron dysregulation outside the brain is an important catalyst that may represent a prodromal mechanistic link in gut-first PD
www.nature.com/articles/s41...
www.nature.com/articles/s41...
August 31, 2025 at 5:50 PM
New review from @malutansey.bsky.social & colleagues explores iron mishandling in the brain & periphery in #Parkinsons, & proposes that iron dysregulation outside the brain is an important catalyst that may represent a prodromal mechanistic link in gut-first PD
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Great visit to the IU Gill Institute for Neuroscience in Bloomington 🤓🤩 hosted by Hui-Chen Lu
August 30, 2025 at 11:38 AM
Great visit to the IU Gill Institute for Neuroscience in Bloomington 🤓🤩 hosted by Hui-Chen Lu
It’s important to focus on our own sphere of influence in these challenging times so thank you #ALZIN Indiana chapter of @alzassociation.bsky.social for hosting Cocktails & Conversation at #LiterHouse
August 29, 2025 at 3:29 AM
It’s important to focus on our own sphere of influence in these challenging times so thank you #ALZIN Indiana chapter of @alzassociation.bsky.social for hosting Cocktails & Conversation at #LiterHouse
Thank you Josh Kulas for the excellent tour of the #IndianaBiosciencesResearchInstitute #IBRI. Looking forward to collaborating with you on #neuroimmunology studies in the #neuroinflammation & #neurodegeneration space 🤓💪🏼🧠🤩 l
August 27, 2025 at 11:53 AM
Thank you Josh Kulas for the excellent tour of the #IndianaBiosciencesResearchInstitute #IBRI. Looking forward to collaborating with you on #neuroimmunology studies in the #neuroinflammation & #neurodegeneration space 🤓💪🏼🧠🤩 l
Excited to share this review from Mackenzie Bolen Kelly Menees, PhD and University of Florida UG Aidan Dupreez in #TanseyLab3ptO on #irondysregulation in the #brain and #periphery in #Parkinsons. www.nature.com/articles/s41...
Iron mishandling in the brain and periphery in Parkinson’s disease - npj Parkinson's Disease
npj Parkinson's Disease - Iron mishandling in the brain and periphery in Parkinson’s disease
www.nature.com
August 19, 2025 at 3:03 AM
Excited to share this review from Mackenzie Bolen Kelly Menees, PhD and University of Florida UG Aidan Dupreez in #TanseyLab3ptO on #irondysregulation in the #brain and #periphery in #Parkinsons. www.nature.com/articles/s41...
Reposted by Prof Malú Gámez Tansey
Women with Down syndrome may develop Alzheimer's disease more rapidly than men news.uci.edu/2025/08/12/w... by @ucirvine.bsky.social
#Alzheimers #dementia #DownSyndrome #WomensHealth @elizabethhead.bsky.social
#Alzheimers #dementia #DownSyndrome #WomensHealth @elizabethhead.bsky.social
Women with Down syndrome may develop Alzheimer's disease more rapidly than men
UC Irvine study finds sex differences may impact treatment approaches
news.uci.edu
August 13, 2025 at 11:39 PM
Women with Down syndrome may develop Alzheimer's disease more rapidly than men news.uci.edu/2025/08/12/w... by @ucirvine.bsky.social
#Alzheimers #dementia #DownSyndrome #WomensHealth @elizabethhead.bsky.social
#Alzheimers #dementia #DownSyndrome #WomensHealth @elizabethhead.bsky.social
Sharing an Op Ed that came out this morning in @rcscience.bsky.social
"A trial provided compelling evidence that it's possible to halt cognitive decline in certain Alzheimer's patients by targeting a protein that causes brain inflammation without simultaneously targeting a related protein that helps protect the brain." www.realclearscience.com/articles/202...
The Dawn of a New Era in Alzheimer’s and Parkinson's Treatment
The human and financial toll of Alzheimer's, Parkinson's, and other neurodegenerative diseases is growing by the day. Over 7 million Americans currently battle Alzheimer's and another 1 million figh
www.realclearscience.com
August 12, 2025 at 2:09 AM
Sharing an Op Ed that came out this morning in @rcscience.bsky.social
Reposted by Prof Malú Gámez Tansey
Please join me for this #Debate on Monday Aug 11 at noon Eastern w my colleague Alberto Espay on the role of #proteinopathies in #neurodegenerativediseases Indiana University School of Medicine #NeurologyGrandRounds Zoom link in QR code
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
August 7, 2025 at 6:53 PM
Please join me for this #Debate on Monday Aug 11 at noon Eastern w my colleague Alberto Espay on the role of #proteinopathies in #neurodegenerativediseases Indiana University School of Medicine #NeurologyGrandRounds Zoom link in QR code
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
Please join me for this #Debate on Monday Aug 11 at noon Eastern w my colleague Alberto Espay on the role of #proteinopathies in #neurodegenerativediseases Indiana University School of Medicine #NeurologyGrandRounds Zoom link in QR code
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
August 7, 2025 at 6:53 PM
Please join me for this #Debate on Monday Aug 11 at noon Eastern w my colleague Alberto Espay on the role of #proteinopathies in #neurodegenerativediseases Indiana University School of Medicine #NeurologyGrandRounds Zoom link in QR code
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
lnkd.in/eFAFXNgC
Meeting ID: 831 3389 0773
Password: 653209
It’s a wrap in #Toronto for @alzassociation.bsky.social #AAIC25 🤓. See you in #London for #AAIC26 😎💜🧠
August 3, 2025 at 3:03 AM
It’s a wrap in #Toronto for @alzassociation.bsky.social #AAIC25 🤓. See you in #London for #AAIC26 😎💜🧠
Exciting topline results from a #Phase2 trial in #Alz presented at #AAIC25 by #INmuneBio showing #solTNFinhibition by #XPro1595 in amyloid positive patients with 2+ biomarkers of inflammation in blood slowed cognitive decline in a 6 mo trial 🤓💪🏼💜🧠
August 3, 2025 at 3:01 AM
Exciting topline results from a #Phase2 trial in #Alz presented at #AAIC25 by #INmuneBio showing #solTNFinhibition by #XPro1595 in amyloid positive patients with 2+ biomarkers of inflammation in blood slowed cognitive decline in a 6 mo trial 🤓💪🏼💜🧠
I incredible transformational studies from the #Neuroimmune consortium presented at the FRS @alzassociation.bsky.social #AAIC25 in #Toronto
August 3, 2025 at 2:57 AM
I incredible transformational studies from the #Neuroimmune consortium presented at the FRS @alzassociation.bsky.social #AAIC25 in #Toronto
Too many #sciencerockstars to count and keep up with at @alzassociation.bsky.social #AAIC25 in #Toronto
August 3, 2025 at 2:53 AM
Too many #sciencerockstars to count and keep up with at @alzassociation.bsky.social #AAIC25 in #Toronto
August 3, 2025 at 2:51 AM
Incredibly proud of these #sciencerockstars & #teamstark colleagues for their awards recognizing their contributions to @alzassociation.bsky.social and @istaart.bsky.social 💜💪🏼🤓 #ENDALZ
August 3, 2025 at 2:47 AM
Incredibly proud of these #sciencerockstars & #teamstark colleagues for their awards recognizing their contributions to @alzassociation.bsky.social and @istaart.bsky.social 💜💪🏼🤓 #ENDALZ
NEWSFLASH #2: @alzassociation.bsky.social commits over $40M to translate the positive outcomes of #USPOINTER #structuredlifestyleintervention to preserve your 🧠 💜 # ENDALZ 💪🏼 from global to local.
July 28, 2025 at 7:27 PM
NEWSFLASH #2: @alzassociation.bsky.social commits over $40M to translate the positive outcomes of #USPOINTER #structuredlifestyleintervention to preserve your 🧠 💜 # ENDALZ 💪🏼 from global to local.